
Number of publications published per year by Bruix, Jordi. (Source : PubMed)

Distribution of publications types for Bruix, Jordi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Hepatocellular carcinoma (HCC): a global perspective.
J. Clin. Gastroenterol.
2010;44;4
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
J. Hepatol.
2010;52;4

MicroRNA analysis for outcome prediction in hepatitis B virus-related liver cancer.
Gastroenterology
2010;138;4
[Treatment of advanced hepatocellular carcinoma.]
Gastroenterol Hepatol
2010

Ablation for hepatocellular carcinoma: Is there need to have a winning technique?
J. Hepatol.
2010;52;3
Treating hepatitis C in patients with cirrhosis: The effort is worth it.
J. Hepatol.
2010
Two decades of advances in hepatocellular carcinoma research.
Semin. Liver Dis.
2010;30;1
Current strategy for staging and treatment: the BCLC update and future prospects.
Semin. Liver Dis.
2010;30;1

Failure of interferon to prevent disease progression and liver cancer in hepatitis C virus infection: proof of absence or absence of proof?
Gastroenterology
2010;138;2

Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic models.
Hepatology
2010;51;1
[ See timeline ] [ See all publications ]
means that Bruix, Jordi has 59 papers cited a least 59 times - methodology
BCLC Group, Liver Unit, Hospital Clínic, Centro de Investigación Biomédica en Red, de Enfermedades Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.